How to build the medical insurance performance evaluation system? 3 key points to teach you to solve difficult problems.
Time of Update: 2020-10-29
health insurance department should make an objective and fair evaluation of the economy, efficiency and efficiency of medical insurance fund expenditure according to the set performance targets, using scientific and reasonable evaluation indicators, evaluation criteria and evaluation methods.
Synthesis and performance impact of membrane-assisted PUD (3)
Time of Update: 2020-09-20
. Table 7 shows that the film-aid PUD prepared in this paper can replace the film-forming additive-assisted PA0 film, can greatly reduce the VOC of water-based coating, although slightly reduce the hardness and water resistance of the coating film, but the compound emulsion coating film can still meet the requirements of water-based wood coating, the total volatile organic compound content (TVOC) in the product is less than 30 g/L.
Can the clinical performance of oral Somaupeptide 3 be shaken?
Time of Update: 2020-06-02
Drug source analysis Although this year's ASCO is considered to be a small year, but ada than the new mechanism is much more, the main reason is that diabetes is a lot of drugs, two is to show the ad
First quarter Science and Technology Board Pharmaceutical Bio Company performed better, 3 performance growth rate of more than 500%
Time of Update: 2020-05-18
[ pharmacy network market analysis ] According to industry statistics combing found that a quarter of this year, hundred Kechuang board company performance differentiation significantly, while the Br
3 pharmaceutical companies have approved injection drugs or have a positive impact on performance
Time of Update: 2020-03-05
According to incomplete industry statistics, as of March 4, a total of 647 injectable drugs (1018 acceptance numbers) have applied /as the application for consistency evaluation, of which 625 additio
Q3 performance of MSD! K pharmaceutical's single quarter revenue of US $3 billion in China increased by 90%
Time of Update: 2019-10-30
On October 29, MSD released the Q3 performance report in 2019 In the first three quarters, the global sales revenue was US $34.972 billion, of which the Q3 sales revenue was US $12.4 billion, up 15% y
The first quarter performance of Shiyao group: 8 innovative drugs with revenue of nearly 3 billion yuan
Time of Update: 2019-05-31
On May 31, medical network reported that prior to the first quarter of 2019, Sinopharm group announced its first quarter results The total revenue of the company was 5.493 billion yuan, a year-on-year
The latest performance of 270 pharmaceutical companies, 7 of which made a steady profit of over 3 billion in the whole year!
Time of Update: 2018-11-05
Medical network on November 5 news at present A-share half year report closed, in general, the vast majority of pharmaceutical companies have earned! ▍ the third quarter ended According to incomplete
Priority evaluation and favorable evaluation: Top 3 of the most beneficial domestic pharmaceutical
Time of Update: 2017-12-26
Since the first batch of priority review varieties at the beginning of 2016, 25 batches of priority review catalogue have been issued, involving nearly 391 acceptance numbers The latest batch of publi
Top 3, the world's best-selling monoclonal antibody, has a mediocre performance in China
Time of Update: 2017-02-21
Source: according to statistics in medical economics report 2017-2-20, the total sales volume of the top 10 best selling drugs in the world in 2016 is expected to reach US $83.121 billion, with monocl